84 related articles for article (PubMed ID: 4393036)
1. [Is there a place for rifampicin in the treatment of bacterial bronchopulmonary infections?].
Maesen FP; Buytendijk HJ
Poumon Coeur; 1970; 26(2):193-7. PubMed ID: 4393036
[No Abstract] [Full Text] [Related]
2. [Value of rifampicin in treatment of the patients with bronchopulmonary lesions. A clinical-bacteriological study].
Beeuwkes H; Buytendijk HJ; Maesen FP
Arzneimittelforschung; 1969 Aug; 19(8):1283-5. PubMed ID: 4390183
[No Abstract] [Full Text] [Related]
3. [Macrolide antibiotics: Streptococcus pneumoniae and Haemophilus influenzae].
Soriano F; Fernández-Roblas R
Enferm Infecc Microbiol Clin; 1996 Oct; 14(8):503-4. PubMed ID: 9011211
[No Abstract] [Full Text] [Related]
4. Rifampicin: a new rifamycin. I. Bacteriological studies.
Arioli V; Pallanza R; Furesz S; Carniti G
Arzneimittelforschung; 1967 May; 17(5):523-9. PubMed ID: 4385644
[No Abstract] [Full Text] [Related]
5. Antibiotic sensitivity of Haemophilus influenzae, Streptococcus pneumoniae, Streptococcus pyogenes and Branhamella catarrhalis isolated from upper respiratory tract infections in Sweden.
Kallings I; Bengtsson S; Christensen P; Holm SE; Lind L; Kalin M
Scand J Infect Dis Suppl; 1983; 39():100-5. PubMed ID: 6359377
[TBL] [Abstract][Full Text] [Related]
6. Macrolide resistance in Streptococci and Haemophilus influenzae.
Bozdogan B; Appelbaum PC
Clin Lab Med; 2004 Jun; 24(2):455-75. PubMed ID: 15177849
[TBL] [Abstract][Full Text] [Related]
7. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L
Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
[TBL] [Abstract][Full Text] [Related]
8. Surveillance of antimicrobial resistance of Streptococcus pneumoniae and Hemophilus influenzae in Thailand.
Bamrungtrakul T; Sunakorn P; Sareebutara W; Vejabhuti A; Lochindarat S; Teeraratkul A; Kittikhun P; Pinyosmosorn R; Wasanawat S; Darnswang SA
J Med Assoc Thai; 1994 Nov; 77(11):572-9. PubMed ID: 7759965
[TBL] [Abstract][Full Text] [Related]
9. Susceptibility of Diplococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis to 23 antibiotics.
Sabath LD; Stumpf LL; Wallace SJ; Finland M
Antimicrob Agents Chemother (Bethesda); 1970; 10():53-6. PubMed ID: 4398824
[No Abstract] [Full Text] [Related]
10. Resistant microorganisms in head and neck infections.
Mazzulli T
J Otolaryngol; 2005 Jun; 34 Suppl 1():S2-6. PubMed ID: 16089233
[TBL] [Abstract][Full Text] [Related]
11. Treatment with appropriate antibiotic therapy in community-acquired respiratory tract infections.
Nicolau DP
Am J Manag Care; 2004 Oct; 10(12 Suppl):S381-8. PubMed ID: 15603247
[No Abstract] [Full Text] [Related]
12. Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the SENTRY Antimicrobial Surveillance Program, 1997-1999.
Hoban DJ; Doern GV; Fluit AC; Roussel-Delvallez M; Jones RN
Clin Infect Dis; 2001 May; 32 Suppl 2():S81-93. PubMed ID: 11320449
[TBL] [Abstract][Full Text] [Related]
13. Respiratory tract infection: epidemiology and surveillance.
Jacobs MR
J Chemother; 1997 May; 9 Suppl 3():10-7. PubMed ID: 9248976
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial agents--mechanisms of action and clinical usage.
Neu HC
Curr Probl Surg; 1973 Jun; ():1-64. PubMed ID: 4146368
[No Abstract] [Full Text] [Related]
15. [Use of methyldichlorophenylisoxazolyl penicillin (staphcillin A) dry syrup in respiratory infections of children].
Niimi H; Terajima S; Muramatsu Y
Jpn J Antibiot; 1969 Feb; 22(1):14-5. PubMed ID: 4389007
[No Abstract] [Full Text] [Related]
16. Evidence-based guidelines for treatment of bacterial respiratory tract infections in the era of antibiotic resistance.
Jacobs MR; Weinberg W
Manag Care Interface; 2001 Apr; 14(4):68-80. PubMed ID: 11339025
[TBL] [Abstract][Full Text] [Related]
17. The crisis of resistant pathogens in respiratory tract infections--use of pharmacodynamic principles.
Palavecino EL
Am J Manag Care; 2001 Jun; 7(6 Suppl):S170-7. PubMed ID: 11424585
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis and group A beta-haemolytic streptococci in 2002-2003. Results of the multinational GRASP Surveillance Program.
Beekmann SE; Heilmann KP; Richter SS; García-de-Lomas J; Doern GV;
Int J Antimicrob Agents; 2005 Feb; 25(2):148-56. PubMed ID: 15664485
[TBL] [Abstract][Full Text] [Related]
19. [Value of quantitative bacteriological examination of sputum in the evaluation of the effectiveness of chemotherapy of bacterial respiratory tract infections. II. Clinical studies].
Nikodemowicz E; Owsiński J; Przybyłkiewicz Z; Kasprowicz A; Maternowska W; Kamińska M; Walaszek K; Prus F
Pneumonol Pol; 1980 Aug; 48(8):545-22. PubMed ID: 6968434
[No Abstract] [Full Text] [Related]
20. [Antimicrobial susceptibility of Streptococcus pyogenes, Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalis from community acquired respiratory infections in 2000].
Melo-Cristino J; Fernandes ML; Serrano N;
Acta Med Port; 2001; 14(5-6):459-68. PubMed ID: 11878155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
